EPIPHANY TECHNOLOGY ACQUISIT's ticker is EPHY and the CUSIP is 29429X109. A total of 95 filers reported holding EPIPHANY TECHNOLOGY ACQUISIT in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,158,532 | -52.5% | 115,770 | -53.1% | 0.00% | – |
| Q3 2022 | $2,438,000 | +352.3% | 246,833 | +350.0% | 0.00% | – |
| Q2 2022 | $539,000 | +54.9% | 54,855 | +54.6% | 0.00% | – |
| Q1 2022 | $348,000 | -85.7% | 35,475 | -85.8% | 0.00% | – |
| Q4 2021 | $2,440,000 | +575.9% | 250,144 | +577.1% | 0.00% | – |
| Q3 2021 | $361,000 | +3.7% | 36,945 | +3.2% | 0.00% | – |
| Q2 2021 | $348,000 | – | 35,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |